Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Farmacosmo SpAMIL:COSMO +0.42%24 Receivables Turnover is 13.03 as of Dec. 2025. GuruFocus rates MIL:COSMO with a GF Score™ of 24/100 and a GF Value™ of €0.74 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 660 Healthcare Providers & Services companies, Farmacosmo SpA ranks better than 84.7% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Farmacosmo SpA's Revenue for the
six
months ended in Dec. 2025 was €27.75 Mil. Farmacosmo SpA's average Accounts Receivable for the
six
months ended in Dec. 2025 was €2.13 Mil.
Hence, Farmacosmo SpA's Receivables Turnover for the
six
months ended in Dec. 2025 was 13.03.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Farmacosmo SpA Receivables Turnover Related Terms
Farmacosmo SpA Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Farmacosmo SpA's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Farmacosmo SpA's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Farmacosmo SpA Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Farmacosmo SpA's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Farmacosmo SpA's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Farmacosmo SpA (MIL:COSMO) has a Receivables Turnover of 13.03 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Farmacosmo SpA and its competitors. According to the industry distribution chart, Farmacosmo SpA ranks #101 out of 660 companies in the Healthcare Providers & Services industry, placing it in the top 15.3%.
Is Farmacosmo SpA's Receivables Turnover too high?
Farmacosmo SpA's current Receivables Turnover is 13.03. The Healthcare Providers & Services industry median Receivables Turnover is 7.75. Farmacosmo SpA's value of 13.03 is 68.2% above this industry median. Based on the distribution chart, Farmacosmo SpA ranks #101 out of 660 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Farmacosmo SpA has a GF Score™ of 24/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Farmacosmo SpA's Receivables Turnover compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Farmacosmo SpA ranks #101 out of 660 companies for Receivables Turnover. This places Farmacosmo SpA in the top 15% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 7.75. Farmacosmo SpA's value of 13.03 is 68.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.75, based on 660 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Farmacosmo SpA's current Receivables Turnover of 13.03 is 68.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Farmacosmo SpA and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Farmacosmo SpA's current Receivables Turnover is 13.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farmacosmo SpA stock overvalued right now?
Based on GuruFocus' analysis, Farmacosmo SpA (MIL:COSMO) is currently considered Possible Value Trap. The stock's GF Value™ is €0.74, compared to a current price of €0.48 — trading 34.9% below its estimated fair value. The current Receivables Turnover is 13.03 and 68.2% above the Healthcare Providers & Services industry median of 7.75. Farmacosmo SpA's overall GF Score™ is 24/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Farmacosmo SpA (MIL:COSMO), the current Receivables Turnover is 13.03 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Farmacosmo SpA (MIL:COSMO) Overvalued in 2026?
Based on GuruFocus' analysis, Farmacosmo SpA stock appears to be undervalued.
The current stock price of €0.48 is trading 34.9% below its estimated GF Value™ of €0.74.
GuruFocus considers Farmacosmo SpA to be Possible Value Trap.
Key valuation signals for MIL:COSMO:
Receivables Turnover: 13.03
GF Value™: €0.74 vs. price of €0.48 (34.9% below fair value)
Industry Position: 68.2% above the Healthcare Providers & Services median (#101 of 660)
No single metric tells the full story. See the MIL:COSMO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Farmacosmo SpA is a wellness e-commerce company active in the Health, Pharma, and Wellness industry, authorized by the Italian Ministry of Health to sell pharmaceutical products online. In particular, the company offers parapharmaceutical products, vitamins and food supplements, dietetic products, medical devices, cosmetic products, personal hygiene products, hair care products, dental care products, skincare products, perfumes, home and baby items.
24GF Score
Get the complete analysis for MIL:COSMO
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:COSMO has been successfully added to your 
